Mount Sinai BioDesign expands collaboration with MedTech community to enhance medical innovation

Mount Sinai Health System today announced that Mount Sinai BioDesign, the medical technology incubator of the Health System, has expanded its reach to become a key, effective partner for the broader MedTech community.

Pyxis cuts staff by 40% and pours resources into two cancer therapies – Pharmaceutical Technology

Pyxis plans to focus on developing its clinical pipeline, which consists of an antibody-drug conjugate (ADC), PYX-201 and a monoclonal antibody, PYX-106. Image Credit: inspiring.team

November 8, 2023

Senate opens probe into how high-risk research poses national security threats

Leaders of the Senate Homeland Security and Governmental Affairs Committee late Wednesday announced a new bipartisan investigation into risky life science research, amid ongoing tensions

March 22, 2024

Alnylam reports positive results for heart drug in pivotal study, likely clearing path to approval

Alnylam Pharmaceuticals said Monday that its treatment for an increasingly common heart condition cut the risk of death and recurrent cardiovascular complications in a key

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.